INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 129 filers reported holding INSMED INC in Q4 2018. The put-call ratio across all filers is 5.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,776,000 | +808.0% | 200,000 | +669.2% | 0.91% | +712.5% |
| Q3 2018 | $526,000 | -97.3% | 26,000 | -95.8% | 0.11% | -97.3% |
| Q3 2017 | $19,488,000 | +139.1% | 624,400 | +31.5% | 4.14% | +144.3% |
| Q2 2017 | $8,151,000 | +104.0% | 475,000 | +137.5% | 1.69% | -39.9% |
| Q2 2014 | $3,996,000 | +55.5% | 200,000 | +48.1% | 2.82% | +84.7% |
| Q1 2014 | $2,570,000 | -24.4% | 135,000 | -32.5% | 1.53% | -27.1% |
| Q4 2013 | $3,400,000 | – | 200,000 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |